Enervimin Stress Focus
94/100
This product looks safe
- Beta-Carotene: 4.5mg is 1.5× the Tolerable Upper Intake Level (3.0mg)
- Niacin/Niacinamide: 120mg is 3.4× the Tolerable Upper Intake Level (35mg)
- Folic Acid: 800mg is 800.0× the Tolerable Upper Intake Level (1.0mg)
- Manganese: 15mg is 1.4× the Tolerable Upper Intake Level (11mg)
- In a 500 mg. proprietary blend of: 500mg is 1.4× the Tolerable Upper Intake Level (350mg)
- 69% of ingredients have research evidence
F
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Beta-Carotene: 4.5mg is 1.5× the Tolerable Upper Intake Level (3.0mg)
⚠️ Niacin/Niacinamide: 120mg is 3.4× the Tolerable Upper Intake Level (35mg)
⚠️ Folic Acid: 800mg is 800.0× the Tolerable Upper Intake Level (1.0mg)
⚠️ Manganese: 15mg is 1.4× the Tolerable Upper Intake Level (11mg)
⚠️ In a 500 mg. proprietary blend of: 500mg is 1.4× the Tolerable Upper Intake Level (350mg)
Label Data
4 Tablet(s)
Serving Size
Other Combinations
Product Type
69%
Evidence Coverage
Supplement Facts — Evidence Check
15000 IU
⚠️ Exceeds Tolerable Upper Intake Level by 1.5× (UL: 3.0 mg)
📚 240 studies (Tier A: 5, B: 97)
Vitamin A
5000 IU
Vitamin C
1000 mg
50 IU
✅ Within RDA (0.1× RDA of 0.015 mg)
📚 604 studies (Tier A: 16, B: 251)
200 IU
📊 8.9× RDA — above typical dose (UL: 1000 mg)
📚 177 studies (Tier A: 3, B: 90)
50 mg
📊 41.7× RDA — above typical dose
📚 76 studies (Tier A: 0, B: 33)
25 mg
📊 19.2× RDA — above typical dose
📚 12 studies (Tier A: 0, B: 1)
120 mg
⚠️ Exceeds Tolerable Upper Intake Level by 3.4× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
25 mg
📊 19.2× RDA — above typical dose (UL: 100 mg)
📚 113 studies (Tier A: 3, B: 35)
800 mg
⚠️ Exceeds Tolerable Upper Intake Level by 800.0× (UL: 1.0 mg)
📚 225 studies (Tier A: 10, B: 105)
100 mcg
📊 41.7× RDA — above typical dose
📚 138 studies (Tier A: 1, B: 44)
300 mcg
📊 10.0× RDA — above typical dose
📚 26 studies (Tier A: 0, B: 11)
150 mg
📊 30.0× RDA — above typical dose
📚 1 studies — no high-quality reviews
Calcium
300 mg
300 mg
📊 Market median: 4002.0mg (1 products)
📚 20 studies (Tier A: 0, B: 2)
20 mg
✅ 1.8× RDA — within safe limits
📚 258 studies (Tier A: 6, B: 134)
200 mcg
📊 3.6× RDA — above typical dose (UL: 0.4 mg)
📚 172 studies (Tier A: 0, B: 67)
2 mg
✅ 2.2× RDA — within safe limits
📚 36 studies (Tier A: 0, B: 11)
15 mg
⚠️ Exceeds Tolerable Upper Intake Level by 1.4× (UL: 11 mg)
📚 8 studies — no high-quality reviews
200 mcg
📊 5.7× RDA — above typical dose
📚 197 studies (Tier A: 1, B: 55)
50 mcg
✅ 1.1× RDA — within safe limits
📚 2 studies — no high-quality reviews
Potassium
75 mg
20 mg
📊 Market median: 125.0mg (294 products)
📚 36 studies (Tier A: 1, B: 7)
25 mg
📊 Market median: 550.0mg (217 products)
📚 29 studies (Tier A: 0, B: 5)
100 mg
📊 Market median: 500.0mg (283 products)
📚 173 studies (Tier A: 0, B: 62)
50 mg
📊 Market median: 500.0mg (9 products)
25 mcg
📊 Market median: 0.5mg (6 products)
📚 1 studies (Tier A: 0, B: 1)
1 mg
📊 Market median: 3.0mg (58 products)
📚 2 studies — no high-quality reviews
⚠️ Exceeds Tolerable Upper Intake Level by 1.4× (UL: 350 mg)
📚 310 studies (Tier A: 8, B: 159)
Label Claims — Verification
❓
All Other
All Other (99% of products)
Structure/Function (76% of products)
Nutrient (58% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
Additional Information
Energique's EnerViMin Stress Focus is formulated to boost the body's defenses against stress.
120 tablets bottle.
Product Details
DSLD Entry Date
2012-10-25
Product Type
Other Combinations
Form
Tablet or Pill
Brand
Energique Nutrition
DSLD ID
13107
Data Updated
2026-04-11
Research Evidence
337
Research Sources
54
Avg Quality Score
161
Meta Analysis
68
Systematic Review
51
Rct
48
Clinical Trial
2
Other
2
Regulatory Source
1
Narrative Review
1
Cochrane Review
1
Guideline
1
Openfda Safety
A
Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
A
Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
A
Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
A
Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
A
Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
A
Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
A
Food fortification with multiple micronutrients: impact on health outcomes in general population
Compare Similar Products
Prenatal/Postnatal
Redmont Pharmaceuticals
100
ActiveMV
dotFIT
100
X7 - Care
OL Olympian Labs
100
Children's Chewable Vite
Rugby
100
Zoo Friends with Xtra C
21st Century Zoo Friends
100